Riskpilot← Back to searchSign inGet full accessAstrieli AB
ABActiveOrg 5568700081Gustavslundsvägen 149 RMedical specialists activities · NACE 8622Est. 20111 employees
Revenue 2025
SEK 0
EBITDA margin
—
+75% vs 2024
Equity ratio
92.5%
Financial strength
Net profit 2025
SEK 1K
+117% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +75% |
| Net profit | SEK 1K | +117% |
| Total assets | SEK 53K | -68% |
| Equity | SEK 49K | +0% |
| Employees | 1 | — |
Legal name
Astrieli AB
Org number
5568700081
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 november 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva medicinsk verksamhet avseende behandling av patienter samt idka därmed förenlig verksamhet. Dessutom ska bolaget kunna bedriva forskning och utveckling samt utbildningsverksamhet inom medicinområdet.
Address
Gustavslundsvägen 149 R
Email
lindstrands@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 766 | 440 | 276 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 493 | 195 | 202 | −8 | −2 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 493 | 195 | 202 | −8 | −2 |
| Net financials | 2 | 2 | 10 | 2 | −1 |
| Profit before tax | 495 | 198 | 212 | −6 | −2 |
| Tax | −102 | −41 | −52 | −0 | 3 |
| Net profit | 393 | 157 | 160 | −6 | 1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 910 | 738 | 504 | 165 | 53 |
| Equity | 608 | 365 | 225 | 49 | 49 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 302 | 373 | 279 | 117 | 3 |
| Total debt | 302 | 373 | 279 | 117 | 3 |
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
20212025
Equity ratio
92.5%
This company
38.2%
Market median
+142% vs market
20212025
Return on equity
2.0%
This company
18.4%
Market median
-89% vs market
20212025
Net profit margin
100000.0%
This company
8.1%
Market median
+1234468% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Astrieli AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Astrid Elisabet Lindstrand | Board of Directors | 0 companies |
| Nils Ire Lindstrand | Deputy Board Member | 0 companies |